SeaSpine Holdings
-
Biologics
SeaSpine Announces 20,000th NanoMetalene® Implantation
CARLSBAD, Calif., July 26, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
SeaSpine Announces Portfolio Expansion of OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers
CARLSBAD, Calif., July 18, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine Announces Full Commercial Launch of Regatta® Lateral System
CARLSBAD, Calif., July 11, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Reports First Quarter 2019 Financial Results
CARLSBAD, Calif., May 01, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance
CARLSBAD, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
Kuros Biosciences Signs Agreement to Supply SeaSpine with Bone Graft Incorporating Kuros’s Advanced Submicron Surface Technology
SCHLIEREN (ZURICH), Switzerland, Feb. 11, 2019 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros…
Read More » -
Financial
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018
CARLSBAD, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
CORRECTING and REPLACING – SeaSpine Announces Preliminary Results for Third Quarter 2018
CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by SeaSpine Holdings…
Read More » -
Spine
SeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior Procedures
Carlsbad, Calif. / Jan. 31, 2018 – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical…
Read More » -
Financial
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017
CARLSBAD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical…
Read More »